Hexanoate

Hexanoate

SCHEMBL350667

CCCCCC(=O)O.COC

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.84
GPR84 Q9NQS5 7/20 0.80
PPARG P37231 7/20 0.80
PPARD Q03181 7/20 0.80
PPARA Q07869 7/20 0.80
HDAC11 Q96DB2 5/20 0.80
TSHR P16473 4/20 0.80
PTPN1 P18031 3/20 0.80
FABP4 P15090 3/20 0.80
ALDH1A1 P00352 2/20 0.80
TLR2 O60603 2/20 0.80
TDP1 Q9NUW8 2/20 0.80
KMT2A Q03164 2/20 0.80
ALOX15 P16050 2/20 0.80
HSD17B10 Q99714 2/20 0.80
SLC22A6 Q4U2R8 1/20 0.80
SLC22A8 Q8TCC7 1/20 0.80
MEN1 O00255 1/20 0.80
ESR1 P03372 1/20 0.80
PDE4A P27815 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptanoate SCHEMBL1245852 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Pentadecanoic Acid SCHEMBL28110788 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Myristic Acid SCHEMBL14716163 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Heptadecanoic Acid SCHEMBL14715846 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Palmitic Acid SCHEMBL14715978 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL1245855 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Nonanoate SCHEMBL14716215 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Decanoic Acid SCHEMBL3288408 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Stearic Acid SCHEMBL14715950 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA
Dodecanoate SCHEMBL2352917 0.97 GPR84 (0.85) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119133770-B Battery diaphragm, biomass polyester adhesive and preparation method thereof 上海恩捷新材料科技有限公司 2025-04-22 CN claimed
US-20120016050-A1 Monoisocyanate-Acrylate Monomers and Products Ulitilizing the Same LEON JOSEPH A (US) 2012-01-19 US claimed
EP-2382244-A1 MONOISOCYANATE-ACRYLATE MONOMERS AND PRODUCTS UTILIZING THE SAME Bomar Specialties Company (US) 2011-11-02 EP claimed
WO-2010074763-A1 MONOISOCYANATE-ACRYLATE MONOMERS AND PRODUCTS UTILIZING THE SAME BOMAR SPECIALTIES COMPANY (US) 2010-07-01 WO claimed
WO-2025027919-A1 AL-ZN-SI-MG HOT-DIPPED STEEL SHEET, SURFACE-TREATED STEEL SHEET, AND COATED STEEL SHEET JFEスチール株式会社 2025-02-06 WO disclosed
CN-117777396-A Heat-sealable aqueous resin composition and laminate 荒川化学工业株式会社 2024-03-29 CN disclosed
EP-3650501-B1 INORGANIC FILLER, POLYARYLENE SULFIDE RESIN COMPOSITION, MOLDED ARTICLE, AND METHODS FOR PRODUCING SAME DAINIPPON INK & CHEMICALS (JP) 2023-06-07 EP disclosed
US-20230077630-A1 WATER-BASED COMPOSITION FOR BARRIER AND LAMINATED MATERIAL ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 2023-03-16 US disclosed
US-20220396712-A1 WATER-BASED OIL RESISTANT AGENT AND OIL RESISTANT PAPER ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 2022-12-15 US disclosed
US-11390744-B2 Inorganic filler, polyarylene sulfide resin composition, molded article, and methods for producing same DIC CORPORATION (JP) 2022-07-19 US disclosed
US-11142629-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element TOKYO OHKA KOGYO CO., LTD. (JP) 2021-10-12 US disclosed
US-20210130626-A1 POLYMER COATING COMPOSITIONS THE BOEING COMPANY 2021-05-06 US disclosed
US-6773855-B1 PRINTED CIRCUIT BOARD HAVING A SOLDER RESIST FILM FORMED FROM THE CURED FILM TAIYO INK MANUFACTURING CO., LTD. (JP) 2004-08-10 US disclosed
EP-1276011-B1 PHOTOCURABLE/THERMOSETTING RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM FORMED THEREFROM, AND METHOD OF FORMING PATTERN WITH THE SAME UNIV KANAGAWA (JP) 2004-05-26 EP disclosed
EP-1416003-A1 RESIN COMPOSITION, COMPOSITION FOR SOLDER RESIST, AND CURED ARTICLE OBTAINED THEREFROM Nippon Kayaku Kabushiki Kaisha (JP) 2004-05-06 EP disclosed
US-20040023120-A1 Photocurable/thermosetting resin composition, photosensitive dry film formed therefrom, and method of forming pattern with the same TAIYO INK MANUFACTURING CO., LTD. (JP) 2004-02-05 US disclosed
EP-1276011-A1 PHOTOCURABLE/THERMOSETTING RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM FORMED THEREFROM, AND METHOD OF FORMING PATTERN WITH THE SAME Kanagawa University (JP) 2003-01-15 EP disclosed
EP-0995765-A1 PROCESS FOR PRODUCING EPOXY ESTER RESINS AND PHOTOSENSITIVE RESIN COMPOSITIONS CONTAINING THEM TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-04-26 EP disclosed
US-5753722-A CONSISTS OF A RESIST COMPOUND HAVING ATLEAST TWO ETHYNICALLY UNSATURATED BONDS, A PHOTOPOLYMERIZABLE INITIATOR, A DILUENT, AN EPOXY COMPOUND HAVING ATLEAST TWO EPXOY GROUPS, FINE ALUMINIUM SILICATE MATING AGENT AND EPOXY RESIN CURING AGENT TAIYO INK MANUFACTURING CO., LTD. (JP) 1998-05-19 US disclosed
EP-0443537-A2 Water soluble photocurable polyurethane poly(meth-)acrylate, adhesives containing the same, and production of laminated articles Takeda Chemical Industries, Ltd. (JP) 1991-08-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016050-A1 Monoisocyanate-Acrylate Monomers and Products Ulitilizing the Same DOHH, ESD, DACH1 AKR1B1 3145/4885GPR84 4609/4885PPARG 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.